Use of a Novel Device for Stretch Relaxation During Mohs Surgery
NCT03586960 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30
Last updated 2018-07-16
Summary
Closure of cutaneous defects is associated with many common and serious problems. For example, Mohs surgery involves the removal of skin and other soft tissues that have been proven to be infiltrated with cancer. Iterative stages of Mohs are processed and examined microscopically for residual tumor. Using specialized mapping, the surgeon can effectively achieve a high cure rate and minimize removal of unaffected tissue. This process usually takes a total of 2-3 hours, since the patient waits while the tissue is being processed, and complete clearance of margins can take multiple stages. In many cases, a cutaneous defect is produced of significant size. In certain areas of high tension, such as scalp and lower leg, this mandates either a lengthy course of wound care or that the surgeon perform a graft or flap. In many cases, performance of a graft is undesirable due to lack of vascularity to support graft survival. Creation of flaps involves incision and undermining of large areas of tissue in order to achieve wound closure. There is a current need for alternatives to graft and flaps in these locations.
Human skin has biomechanical properties that can be harnessed to facilitate closure of larger wounds. Stress-relaxation refers to the natural relaxation exhibited by skin put under a given amount of tension (stress) over time. After a period of stress, the force required to close the wound is reduced. In a porcine skin wound model, there is a 40-60% reduction in stress after twenty minutes of stretch relaxation.
There are several classic methods of delivering this stretch to skin intraoperatively. Most simply, a towel clamp can be used to bring edges together. However, the clamp, which is a sharp stainless steel instrument, can damage tissues. There are also commercial devices such as TopClosure. However, this device is intended for very large wounds with side plates that must be sutured or stapled to patient skin.
The SUTUREGARD device presents a simple method to provide stress to a wound but not damage tissue. The SUTUREGARD device results in significantly lower pressure on the skin when compared with traditional sutures and creates a much greater volume of wound eversion than is possible with a traditional suturing method. Engineering tests performed at OSU showed that a given simple interrupted suture will exert about 30% less pressure on the skin when used performed with the device compared to without the device. With this protection, this creates the corollary that a suture could be safely tied to a greater force with the device than without. In animal testing, the device has been used on porcine wounds for up to 6 weeks, where it showed superior histologic tolerability over traditional sutures.
The investigators have used the device to provide stress-relaxation within our clinic over the past several months and have seen reductions in wound width of about 30% with retention of the device for 30-60 minutes. Wounds exhibit significantly more reduction in width with overnight use. Unlike traditional retention sutures, which damage the skin, the skin appears normal with retention of the device for up to 2 days in our patients. Furthermore, all wounds that have been stress-relaxed with the device have healed without complication.
The investigators plan to study the stress-relaxation created by use of a SUTUREGARD device applied to cutaneous defects for a specified time periods (30, 60 and 90 minutes).
Conditions
- Tissue Expander Disorder
- Stress Strain Curve
- Tissue Expansion
- Mohs Surgery
Interventions
- DEVICE
-
Peak Force Measurement
Force will be measured at 5,10, and 30 minutes
Sponsors & Collaborators
-
Silver Falls Dermatology
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- BASIC_SCIENCE
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2018-07-02
- Primary Completion
- 2018-08-31
- Completion
- 2018-09-30
- FDA Device
- Yes
Countries
- United States
Study Locations
More Related Trials
-
Laser Treatment for the Improvement of Scars and Scleroderma
NCT04567537 ·Status: TERMINATED ·Phase: NA
-
Treatment of Self Harm Scars With Fraxel Laser
NCT05363969 ·Status: UNKNOWN ·Phase: NA
-
Efficacy of Skin Cooling in Reducing Pain Associated With Non-invasive Treatments of Neurofibromatosis Type 1 Cutaneous Neurofibromas
NCT06132165 ·Status: COMPLETED ·Phase: PHASE1
-
Secondary Intention Wound Healing Versus Micrografting in Patients Undergoing Mohs Surgery
NCT01442844 ·Status: TERMINATED ·Phase: NA
-
Measuring the Volumes of Hypertrophic Scars and Keloids, Two Specific Kind of Scars, Over Different Points in Time in Patients Who Have Undergone Surgery and Evaluate 3D-cameras As a Possible Measuring and Documenting Tool Including Volumetry
NCT06806735 ·Status: RECRUITING
-
Comparison of Traditional Superficial Cutaneous Sutures Versus Steri-Strip Coaptive Film in Layered Dermatologic Closures
NCT01938586 ·Status: COMPLETED
-
Transcutaneous Oxygen as a Predictor of Wound Healing Complications in Preoperatively Radiated Soft Tissue Sarcoma
NCT02897128 ·Status: COMPLETED
-
SNaP Wound Care System Over Skin Cancer Excision Sites and Split Thickness Skin Grafts (STSGs)
NCT01349894 ·Status: WITHDRAWN
-
Fractionated Carbon Dioxide Laser and Burn Scar Contractures: Evaluation of Post-Treatment Scar Function and Appearance
NCT02115646 ·Status: COMPLETED ·Phase: NA
-
CO2 Laser Revision for Burn Related Donor Site Scars
NCT04456127 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Pinch Grafting Versus Second Intention Wound Healing for Mohs Micrographic Surgery Defects on the Scalp
NCT06287866 ·Status: RECRUITING ·Phase: NA
-
Treatment of Surgical Scars With Fractional Photothemolysis Versus Pulse Dye Laser
NCT00685243 ·Status: COMPLETED ·Phase: NA
-
Treatment of Patients With Non-healing Wounds and Trophic Ulcers Using Autologous Dermal Fibroblasts
NCT04483934 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Effect of Externally Implantable Tissue Expansion Device on Scar Length
NCT00798798 ·Status: WITHDRAWN ·Phase: NA
-
In-vivo Analysis of a Fractional CO2 Laser System (eMatrixCO2) Intended for Treatment of Soft Tissue
NCT01026662 ·Status: UNKNOWN
-
Comparing Pressure Versus Simple Adhesive Dressing After Mohs Reconstruction
NCT02780934 ·Status: COMPLETED ·Phase: NA
-
Pilot Study of a Novel 532nm KTP Laser for the Treatment of Fresh Surgical Scars
NCT01789346 ·Status: COMPLETED ·Phase: NA
-
Timing of Suture Removal to Reduce Scarring in Skin Surgery
NCT05036785 ·Status: COMPLETED ·Phase: NA
-
A Skin Stretching Wound Closure System
NCT01069614 ·Status: UNKNOWN ·Phase: PHASE1
-
Study of Silicone Material Inserts To Treat Burn Scars
NCT03159182 ·Status: WITHDRAWN ·Phase: NA
-
Dermabrasion for Free Flap Aesthetic Enhancement
NCT07233200 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Effect of Extracorporeal Shock Wave Therapy for Burn Scar Charateristics
NCT04187586 ·Status: COMPLETED
-
Ablative Fractional Laser for Sclerotic GVHD-Associated Joint Contractures
NCT02881047 ·Status: TERMINATED ·Phase: NA
-
Ablative 10600 nm Fractional Laser Therapy for the Treatment of Scars
NCT01358838 ·Status: COMPLETED ·Phase: NA
-
Hyaluronidase Via LADD Scleroderma-induced Microstomia
NCT05995626 ·Status: COMPLETED ·Phase: EARLY_PHASE1